St. Louis-based Ascension, which signed a definitive agreement on June 17 to acquire ASC operator AmSurg, reported a fiscal 2025 operating loss of $490.9 million (a -1.6% operating margin), a significant improvement from its $1.8 billion loss (-6.3% margin) the prior year.
Here are five key takeaways from Ascension’s quarterly performance
1. Operating results for 2025 included $81 million in one-time, non-cash write-downs and other nonrecurring losses, down from $402 million in such charges in 2024.
2. Total revenue declined 11.3% year over year to $25.3 billion for the 12 months ending June 30. On a same-facility basis, adjusted to reflect portfolio changes, total operating revenue rose 6.6%.
3. Total operating expenses fell 14.1% year over year to $25.83 billion in 2025. When viewed on a same-facility basis, expenses ticked up just 0.1% from the prior year.
4. Salaries, wages and benefits declined 15.2% overall and 1.5% on a same-facility basis. The system attributed these decreases to workforce stabilization and labor efficiency efforts, which have helped reduce staff turnover.
5. Ascension posted net income of $918 million in 2025, a sharp turnaround from a net loss of $1.1 billion in 2024.
